HIGHLIGHTS
- who: Jun-Yan Liu et al. from the Jiaotong University, China have published the research: LASTR is a novel prognostic biomarker and predicts response to cancer immunotherapy in gastric cancer, in the Journal: (JOURNAL)
- how: The authors analyzed the prognostic value of LASTR expression among patient with GC and the potential function in_vitro experiments. This analysis was based on the fact that there was a RNA isolation and RT-PCR TRIzol (Invitrogen Thermo Fisher Scientific Inc.) was applied to extract total RNA from GC samples and cells and then the total RNA was reverse-transcribed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.